RoslinTech has closed an £11m Series A capital raise, led by life sciences investor Novo Holdings.
This investment aims to fuel the company's next wave of growth in its mission to become the leading provider of animal cell lines to the cultivated meat sector.
Cultivated meat is grown directly from animal cells without the need to raise animals, promising to improve animal welfare, lower antibiotics use and reduce the environmental footprint of food production.
